BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25896442)

  • 1. Increased hippocampal blood volume and normal blood flow in schizophrenia.
    Talati P; Rane S; Skinner J; Gore J; Heckers S
    Psychiatry Res; 2015 Jun; 232(3):219-25. PubMed ID: 25896442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach.
    Wirestam R; Knutsson L; Risberg J; Börjesson S; Larsson EM; Gustafson L; Passant U; Ståhlberg F
    Acta Radiol; 2007 Jun; 48(5):550-6. PubMed ID: 17520432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion.
    Knutsson L; Lindgren E; Ahlgren A; van Osch MJ; Bloch KM; Surova Y; Ståhlberg F; van Westen D; Wirestam R
    Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow, blood volume, and mean transit time responses to propofol and indomethacin in peritumor and contralateral brain regions: perioperative perfusion-weighted magnetic resonance imaging in patients with brain tumors.
    Rasmussen M; Juul N; Christensen SM; Jónsdóttir KY; Gyldensted C; Vestergaard-Poulsen P; Cold GE; Østergaard L
    Anesthesiology; 2010 Jan; 112(1):50-6. PubMed ID: 19952725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging.
    Gasparovic CM; Roldan CA; Sibbitt WL; Qualls CR; Mullins PG; Sharrar JM; Yamamoto JJ; Bockholt HJ
    J Rheumatol; 2010 Sep; 37(9):1834-43. PubMed ID: 20551095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral vascular mean transit time in healthy humans: a comparative study with PET and dynamic susceptibility contrast-enhanced MRI.
    Ibaraki M; Ito H; Shimosegawa E; Toyoshima H; Ishigame K; Takahashi K; Kanno I; Miura S
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):404-13. PubMed ID: 16736045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging.
    Helenius J; Perkiö J; Soinne L; Østergaard L; Carano RA; Salonen O; Savolainen S; Kaste M; Aronen HJ; Tatlisumak T
    Acta Radiol; 2003 Sep; 44(5):538-46. PubMed ID: 14510762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in perfusion imaging by bolus tracking.
    Oslash Stergaard L
    J Neuroradiol; 2005 Dec; 32(5):315-20. PubMed ID: 16424830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of cerebral perfusion imaging by bolus tracking.
    Østergaard L
    J Magn Reson Imaging; 2005 Dec; 22(6):710-7. PubMed ID: 16261573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol-induced changes in cerebral blood flow and cerebral blood volume in social drinkers.
    Gundersen H; van Wageningen H; Grüner R
    Alcohol Alcohol; 2013; 48(2):160-5. PubMed ID: 23171612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cerebral blood volume (CBV) measured by dynamic susceptibility contrast MRI and 99mTc-RBC SPECT.
    Engvall C; Ryding E; Wirestam R; Holtås S; Ljunggren K; Ohlsson T; Reinstrup P
    J Neurosurg Anesthesiol; 2008 Jan; 20(1):41-4. PubMed ID: 18157024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of graded hypotension on cerebral blood flow, blood volume, and mean transit time in dogs.
    Ferrari M; Wilson DA; Hanley DF; Traystman RJ
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1908-14. PubMed ID: 1621847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging.
    Perkiö J; Aronen HJ; Kangasmäki A; Liu Y; Karonen J; Savolainen S; Østergaard L
    Magn Reson Med; 2002 May; 47(5):973-81. PubMed ID: 11979577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hemodynamic changes measured by gradient-echo or spin-echo bolus tracking and its correlation to changes in ICA blood flow measured by phase-mapping MRI.
    Marstrand JR; Rostrup E; Rosenbaum S; Garde E; Larsson HB
    J Magn Reson Imaging; 2001 Oct; 14(4):391-400. PubMed ID: 11599063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain hemodynamic changes associated with chronic cerebrospinal venous insufficiency are not specific to multiple sclerosis and do not increase its severity.
    Garaci FG; Marziali S; Meschini A; Fornari M; Rossi S; Melis M; Fabiano S; Stefanini M; Simonetti G; Centonze D; Floris R
    Radiology; 2012 Oct; 265(1):233-9. PubMed ID: 22915599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive MRI measurement of the absolute cerebral blood volume-cerebral blood flow relationship during visual stimulation in healthy humans.
    Ciris PA; Qiu M; Constable RT
    Magn Reson Med; 2014 Sep; 72(3):864-75. PubMed ID: 24151246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.
    Hirai S; Inaji M; Tanaka Y; Hara S; Nariai T; Maehara T
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2814-2820. PubMed ID: 28778721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans.
    Grandin CB; Bol A; Smith AM; Michel C; Cosnard G
    Neuroimage; 2005 Jun; 26(2):525-35. PubMed ID: 15907309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.